Stocks In Play


(MENAFN- Baystreet) Lithium South Development Corp
4/2/2024 9:27 AM EST

  • Oncolytics Biotech Inc
    4/2/2024 9:23 AM EST
  • CareRx Corporation
    4/1/2024 11:11 AM EST
  • Equinox Gold Corp.
    4/1/2024 11:02 AM EST
  • Aurora Cannabis Inc.
    4/1/2024 10:28 AM EST
  • Parkland Corporation
    4/1/2024 10:24 AM EST
  • Rakovina Therapeutics Inc.
    4/1/2024 10:03 AM EST
  • Boardwalktech Software Corp
    4/1/2024 9:59 AM EST
  • Enthusiast Gaming Holdings Inc.
    4/1/2024 9:55 AM EST
  • Telesat
    4/1/2024 9:51 AM EST Previous Articles Subscribe to Get Small Cap News & Alerts Baystreet Staf - Tuesday, April 2, 2024

    Stocks in Play

    4/2/2024 - 9:33 AM EST - Else Nutrition Holdings Inc : Announces the first roll-out of its infant formula in Australia and New Zealand, setting the stage for a planned expansion of its entire product line across the over US$50 billion Asia Pacific baby, infant and toddler food market. The infant formula for children 6-12 month old, as well as Else's toddler drink for children 12-36 months old, are now available on Amazon Australia. Else Nutrition Holdings Inc shares T are trading down one cent at $0.28.

    Full Press Release:





    • About Us
    • Contact Us
    • Advertise
    • License Our Content
    • Jobs
    • Disclaimer
    • Privacy Policy

    Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks

    MENAFN02042024000212011056ID1108049244


  • Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.